In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19 - Zhang, Xiao-Jing; Qin, Juan-Juan; Cheng, Xu; Shen, Lijun; Zhao, Yan-Ci; Yuan, Yufeng; Lei, Fang; Chen, Ming-Ming; Yang, Huilin; Bai, Liangjie; Song, Xiaohui; Lin, Lijin; et al. (Cell metabolism, 2020)
Keywords: ACEi/ARB; Aged; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Antihypertensive Agents - therapeutic use; Betacoronavirus - drug effects; Comorbidity; Coronavirus Infections - drug therapy; Coronavirus Infections - mortality; COVID-19; Cytokine Release Syndrome - drug therapy; Drug Repositioning - methods; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Hypertension - drug therapy; Male; Middle Aged; mortality; Pandemics; Peptidyl-Dipeptidase A - drug effects; Pneumonia, Viral - drug therapy; Pneumonia, Viral - mortality; Retrospective Studies; SARS-COV-2; statin; COVID-19; mortality; ACEi/ARB; statin; SARS-COV-2